vTv Therapeutics (VTVT) – Litigation
-
vTv Therapeutics (VTVT) Announces Issuance of U.S. Patent for Azeliragon as a Treatment of Glioblastoma to Cantex Pharmaceuticals
-
vTv Therapeutics (VTVT) Announces Issuance of U.S. Patent Covering Methods of Treatment Using TTP399
Back to VTVT Stock Lookup